Latest filing published 13 Mar 2017 for Intellia Therapeutics, Inc., €205k.
Filing timeline
BuySaleInsider track record
Atlas Venture Associates IX, L.P.: trading record in brief
This profile gathers the share dealings of Atlas Venture Associates IX, L.P. in Intellia Therapeutics, Inc. We count 2 filings; the first trade dates from 9 March 2017 and the latest from 10 March 2017.
The open-market record consists of 2 sales worth €278k, with no purchase.
The newest entry dates from 13 March 2017: an open-market sale of €205k, in Intellia Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Atlas Venture Associates IX, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,628 shares@ US$13.84973.7% of flowCommon StockSEC:0001209191-17-020055:0
- 5,504 shares@ US$14.064426.3% of flowCommon StockSEC:0001209191-17-020055:1
2 of 2 declarations
